The Global Rheumatoid Arthritis Treatment Market Is Witnessing High Growth Owing To the Increasing Prevalence of Arthritis in the World

Rheumatoid arthritis, also called systemic sclerosis, is a progressive autoimmune disease that affects the joints, bones, and ligaments of the body. It is a disorder that affects the lining of the joints; however, it can also affect tendons, muscles, nerves, and other organs. It commonly begins in the late teen years or early twenties and most sufferers will eventually experience joint destruction and loss of function over time. Sufferers may be diagnosed with Rheumatoid Arthritis when they have first noticed joint pain or stiffness, but sometimes the disease may be in the symptoms for years before a diagnosis is made. It is important to diagnose and treat Rheumatoid Arthritis properly in order to prevent further damage to the joints, tendons, and muscles.

The increasing incidence of Rheumatoid Arthritis in the world is the main factor that is augmenting the growth of the global rheumatoid arthritis treatment market. For instance, according to Medscape, the global annual incidence of rheumatoid arthritis is around 3 cases per 10,000 individuals and the net prevalence rate is around 1% and increases with age and peaks between 35 and 50 years. Moreover, the increasing launches of advanced and developed services and products in order to fight the increasing incidence of the diseases is also enhancing the growth of the global rheumatoid arthritis treatment market.

The global rheumatoid arthritis treatment market is estimated to be valued at US$ 40.5 Bn in 2021, and is expected to exhibit a CAGR of around 6% over the forecast period (2021 – 2031).

Coherent Market Insights celebrating 5th anniversary and offering 2000 USD off on all reports. Let’s celebrate with us.

Buy Now and Get Instant Discount: https://www.coherentmarketinsights.com/promo/buynow/166

Key Market Segments
By Drug Class
Disease-modifying Anti-rheumatic Drugs (DMARDs)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Uric Acid Drugs
Others

By Route of Administration
Oral
Parenteral

By Sales Channel
Prescription-based Drugs
Over-the-counter Drugs

If scientists do find that a specific protein or set of proteins is the cause of rheumatoid arthritis, then future research will need to determine how to target and eliminate the protein. The ultimate goal is to find a treatment for rheumatoid arthritis that works effectively in both prevention and treating the disease. Currently, there is no cure for rheumatoid arthritis, but there are some effective treatments to help those who suffer from the disease. In addition to daily anti-inflammatory medications, patients are encouraged to eat a healthy diet, get plenty of sleep, and exercise regularly. However, the cost of rheumatoid arthritis treatment is the main restraining factor that is hindering the growth of the global rheumatoid arthritis treatment market.

With the increasing prevalence of rheumatoid arthritis in the region, North America is experiencing a rising demand in the global rheumatoid arthritis treatment market. For instance, according to the Centers for Disease Control and Prevention, in the United States, around 23% of all individuals (more than 54 million individuals) suffer from arthritis. Around 24 million individuals have limited their activities owing to arthritis and over 1 in 4 adults report severe joint pain. Moreover, the increasing prevalence of key market players in the region is also aiding the market growth and all have also enabled various industrial developments in the global rheumatoid arthritis treatment market. For instance, in August 2019, the U.S Food and Drug Administration approved RINVOQ (upadacitinib) developed by AbbVie, which is an oral JAK Inhibitor that is used in treating moderate to severe rheumatoid arthritis.

Read more @ https://www.coherentmarketinsights.com/ongoing-insight/rheumatoid-arthritis-treatment-market-166

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle,
WA 98154, U.S.
Phone:
US: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com

About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.

This release was published on openPR.